Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:00 UTC |
---|
HMDB ID | HMDB0015509 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Ethylmorphine |
---|
Description | Ethylmorphine, also known as dionine or trachyl, belongs to the class of organic compounds known as morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic. Morphine interacts predominantly with the opioid mu-receptor. Ethylmorphine is a very strong basic compound (based on its pKa). In humans, ethylmorphine is involved in ethylmorphine action pathway. It is not marketed in the US but is approved for use in various countries around the world. In addition to analgesia, alterations in mood, euphoria and dysphoria, and drowsiness commonly occur. It is metabolized in the liver by ethylmorphine-N-demethylase and used as an indicator of liver function. |
---|
Structure | [H][C@@]12OC3=C(OCC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O InChI=1S/C19H23NO3/c1-3-22-15-7-4-11-10-13-12-5-6-14(21)18-19(12,8-9-20(13)2)16(11)17(15)23-18/h4-7,12-14,18,21H,3,8-10H2,1-2H3/t12-,13+,14-,18-,19-/m0/s1 |
---|
Synonyms | Value | Source |
---|
Dionine | HMDB | Ethyl morphine | HMDB | Ethylmorphine, (5alpha,6beta)-isomer | HMDB | Novartis brand OF ethylmorphine hydrochloride, (5alpha,6alpha)-isomer | HMDB | Trachyl | HMDB | Ethomorphine | HMDB | Ethylmorphine hydrochloride, (5alpha,6alpha)-isomer | HMDB | Ethylmorphine sulfate (2:1), (5alpha,6alpha)-isomer | HMDB | Ethylmorphine hydrochloride, dihydrate, (5alpha,6alpha)-isomer | HMDB |
|
---|
Chemical Formula | C19H23NO3 |
---|
Average Molecular Weight | 313.3908 |
---|
Monoisotopic Molecular Weight | 313.167793607 |
---|
IUPAC Name | (1S,5R,13R,14S,17R)-10-ethoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10,15-tetraen-14-ol |
---|
Traditional Name | ethylmorphine |
---|
CAS Registry Number | 76-58-4 |
---|
SMILES | [H][C@@]12OC3=C(OCC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O |
---|
InChI Identifier | InChI=1S/C19H23NO3/c1-3-22-15-7-4-11-10-13-12-5-6-14(21)18-19(12,8-9-20(13)2)16(11)17(15)23-18/h4-7,12-14,18,21H,3,8-10H2,1-2H3/t12-,13+,14-,18-,19-/m0/s1 |
---|
InChI Key | OGDVEMNWJVYAJL-LEPYJNQMSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Morphinans |
---|
Sub Class | Not Available |
---|
Direct Parent | Morphinans |
---|
Alternative Parents | |
---|
Substituents | - Morphinan
- Phenanthrene
- Tetralin
- Coumaran
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Benzenoid
- Secondary alcohol
- Tertiary amine
- Tertiary aliphatic amine
- Ether
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Alcohol
- Hydrocarbon derivative
- Organic nitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 199 - 201 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.84 g/L | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Ethylmorphine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0671-1090000000-ee6bb48baf50c5f0670d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethylmorphine GC-MS (1 TMS) - 70eV, Positive | splash10-00fr-8019000000-beb618b0f58f701fb24e | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethylmorphine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethylmorphine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 10V, Positive-QTOF | splash10-03di-0049000000-e64f6928d31bc2f5e107 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 20V, Positive-QTOF | splash10-03di-1095000000-59a9dd24e82a0c7408b8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 40V, Positive-QTOF | splash10-0pvi-2090000000-b870f6f4d523dfc80ab1 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 10V, Negative-QTOF | splash10-03di-0029000000-34c8963f215272a01a9b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 20V, Negative-QTOF | splash10-03e9-1095000000-566ee946086b9b47cb7a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 40V, Negative-QTOF | splash10-00os-2090000000-2f55fa4e64af44c96a21 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 10V, Positive-QTOF | splash10-03di-0009000000-879645690cd5fc806db2 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 20V, Positive-QTOF | splash10-03di-0049000000-f058a1d6993a96cbdcbe | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 40V, Positive-QTOF | splash10-0k92-0091000000-89c269fb29eb1ca16959 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 10V, Negative-QTOF | splash10-03di-0009000000-19200665d806a98057c5 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 20V, Negative-QTOF | splash10-03di-0039000000-ded7c070e5e8b4cb3500 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethylmorphine 40V, Negative-QTOF | splash10-001i-0091000000-7a013b74465d3642aeaa | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - Aasmundstad TA, Xu BQ, Johansson I, Ripel A, Bjorneboe A, Christophersen AS, Bodd E, Morland J: Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose. Br J Clin Pharmacol. 1995 Jun;39(6):611-20. [PubMed:7654478 ]
- Xu BQ, Aasmundstad TA, Lillekjendlie B, Bjorneboe A, Christophersen AS, Morland J: Effects of ethanol on ethylmorphine metabolism in isolated rat hepatocytes: characterization by means of a multicompartmental model. Pharmacol Toxicol. 1997 Apr;80(4):171-81. [PubMed:9140136 ]
|
---|